Overview
Viera Sandecka practices practicing medicine in Brno, Czech Republic.
Ms. Sandecka is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Chronic Inflammatory Response Syndrome (CIRS), Plasmacytoma, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 50 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Viera Sandecka
Is Viera Sandecka a top-rated expert for Monoclonal Gammopathy of Undetermined Significance (MGUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Viera Sandecka is classified as an Distinguished expert for Monoclonal Gammopathy of Undetermined Significance (MGUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Viera Sandecka participate in research or clinical trials?
Yes. Viera Sandecka has published 50 articles and abstracts on conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS). You can view a list of Viera Sandecka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaMs. Sandecka isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Chronic Inflammatory Response Syndrome (CIRS)
- PlasmacytomaMs. Sandecka isAdvanced. Learn about Plasmacytoma.
- Waldenstrom MacroglobulinemiaMs. Sandecka isAdvanced. Learn about Waldenstrom Macroglobulinemia.
- XanthomaMs. Sandecka isAdvanced. Learn about Xanthoma.
- Experienced
- Bone Marrow TransplantMs. Sandecka isExperienced. Learn about Bone Marrow Transplant.
- Castleman DiseaseMs. Sandecka isExperienced. Learn about Castleman Disease.
- Cavernous LymphangiomaMs. Sandecka isExperienced. Learn about Cavernous Lymphangioma.
- Erdheim-Chester DiseaseMs. Sandecka isExperienced. Learn about Erdheim-Chester Disease.
- Gilbert SyndromeMs. Sandecka isExperienced. Learn about Gilbert Syndrome.
- Hereditary Hemorrhagic TelangiectasiaMs. Sandecka isExperienced. Learn about Hereditary Hemorrhagic Telangiectasia.
- HistiocytosisMs. Sandecka isExperienced. Learn about Histiocytosis.
- HivesMs. Sandecka isExperienced. Learn about Hives.
- Kienbock's DiseaseMs. Sandecka isExperienced. Learn about Kienbock's Disease.
- LymphangiomatosisMs. Sandecka isExperienced. Learn about Lymphangiomatosis.
- Lymphofollicular HyperplasiaMs. Sandecka isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphoid HyperplasiaMs. Sandecka isExperienced. Learn about Lymphoid Hyperplasia.
- Non-Langerhans-Cell HistiocytosisMs. Sandecka isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaMs. Sandecka isExperienced. Learn about Reticulohistiocytoma.
- Rosai-Dorfman DiseaseMs. Sandecka isExperienced. Learn about Rosai-Dorfman Disease.
- Rotor SyndromeMs. Sandecka isExperienced. Learn about Rotor Syndrome.
- ScleredemaMs. Sandecka isExperienced. Learn about Scleredema.
- Smoldering Multiple MyelomaMs. Sandecka isExperienced. Learn about Smoldering Multiple Myeloma.